India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
What is the risk of diabetes in children? The problem of diabetes in children is increasing, there are various reasons for this. To solve this problem, it is very important to understand its cause. Mainly, there are two types of diabetes, type-1 and type-2 diabetes. Both these types of diabetes occur in children for various reasons. genetic cause If the child has a family history of diabetes, the child is more likely to develop diabetes. Type-1 diabetes is often caused by genetic factors, which include the destruction of the insulin-producing cells in the pancreas. If any member of the family has type-1 diabetes, the child is more likely to develop this disease. Unhealthy lifestyle Today's children consume more junk food and sugary foods. These substances increase the level of sugar in the body, which hinders the action of insulin. Lack of physical activity and staying indoors also increases the risk of diabetes. obesity Obesity is the leading cause of diabetes in children. When a...